A STUDY TO ASSESS, MONITOR, AND REPORTING OF ADVERSE DRUG REACTIONS IN A TERTIARY CARE TEACHING HOSPITAL: HIMS, HASSAN

Authors

  • Bhavishya KA Valder Department of Pharmacology, HIMS, Hassan, Karnataka, India.
  • NEELAMMA P Department of Pharmacology, HIMS, Hassan, Karnataka, India.
  • Nalini GK Department of Pharmacology, HIMS, Hassan, Karnataka, India.
  • Sahana GN Department of Pharmacology, HIMS, Hassan, Karnataka, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i7.46654

Keywords:

Adverse drug reaction, Adverse drug event, Pharmacovigilance

Abstract

Objective: An adverse drug reaction (ADR) is an unwanted, undesirable effect of a medication that occurs during usual clinical use. ADR should be quickly identified and managed to limit their detrimental effects on the patient. This study was undertaken to characterize the pattern of ADRs reported through spontaneous reporting system at ADR reporting unit in a tertiary care teaching hospital.

Methods: A prospective, observational study was conducted over 3 years between September, 2017 and August, 2019. The ADRs reported were from patients admitted inpatient department of hospital. Evaluation of patient demographics, drug and ADR characteristics, and outcome of the ADRs. Causality and severity assessment was done by the World Health Organization system and Naranjos scale.

Results: 82 cases of ADRs were reported during the study period. More number of ADRs was from General Medicine and Pediatric departments, in which the most affected organ systems were the skin and the gastrointestinal tract. The antibiotic classes mostly accounted were cephalosporins. None of the ADR was fatal.

Conclusion: ADRs to antibiotics are common and will be resulted in increased health-care cost due to the need of some interventions and increased length of hospital stay. The health-care system should promote proper documentation and periodic reporting to regional pharmacovigilance centers to ensure drug safety.

Downloads

Download data is not yet available.

References

Gallelli L, Ferreri G, Colosimo M, Pirritano D, Flocco MA, Pelaia G, et al. Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy. Pharmacol Res 2003;47:493-9. doi: 10.1016/s1043- 6618(03)00003-3, PMID 12742002

Novotný J, Novotný M. Adverse drug reactions to antibiotics and major antibiotic drug interactions. Gen Physiol Biophys 1999;18 Spec No:126-39. PMID 10703731

Sultana J, Cutroneo P, Trifirò G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother 2013;4(Suppl 1):S73-7. doi: 10.4103/0976-500X.120957, PMID 24347988

Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, et al. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley. BMC Clin Pharmacol 2007;7:9.

Priyadharsini R, Surendiran A, Adithan C, Sreenivasan S, Sahoo FK. A study on adverse drug reactions in paediatric patients. J Pharmacol Pharmacother 2011;2:277-80. doi: 10.4103/0976-500X.85957, PMID 22025857

Mehta DJ. Methods of reporting adverse drug reactions. Indian J Pharmacol 1972;4:67-74.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients-a meta-analysis of prospective studies. JAMA 1998;279:1200-5. doi: 10.1001/jama.279.15.1200, PMID 9555760

Sahu RK, Yadav R, Prasad P, Roy A, Chandrakar S. Adverse drug reactions monitoring: Prospects and impending challenges for pharmacovigilance. Springerplus 2014;3:695. doi: 10.1186/2193- 1801-3-695, PMID 25520913

Arnott J, Hesselgreaves H, Nunn AJ, Peak M, Pirmohamed M. What can we learn from parents about enhancing participation in pharmacovigilance? Br J Clin Pharmacol 2012;78:312-22.

Jose J, Rao PM, Archana B. Implementation and results of an adverse drug reaction reporting programme at an Indian teaching hospital. Indian J Pharmacol 2006;38:293-4. doi: 10.4103/0253-7613.27032

Rehan HS, Chopra D, Sah RK, Mishra R. Adverse drug reactions: Trends in a tertiary care hospital. Curr Drug Saf 2012;7:384-8. doi: 10.2174/157488612805076598, PMID 23150923

Shamna M, Dilip C, Ajmal M, Mohan PL, Shinu C, Jafer CP, et al. A prospective study on adverse drug reactions of antibiotics in a tertiary care hospital. Saudi Pharm J 2014;22:303-8. doi: 10.1016/j. jsps.2013.06.004, PMID 25161373

Shrivastava M, Uchit G, Chakravarti A, Joshi G, Mahatme M, Chaudhari H. Adverse drug reactions reported in Indira Gandhi government medical college and hospital, Nagpur. J Assoc Physicians India 2011;59:296-9. PMID 21751606

Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res 2006;54:226-33. doi: 10.1016/j.phrs.2006.05.003, PMID 16781163

Giardina C, Cutroneo PM, Mocciaro E, Russo GT, Mandraffino G, Basile G, et al. Adverse drug reactions in hospitalized patients: Results of the FORWARD (facilitation of reporting in hospital ward) study. Front Pharmacol 2018;9:350. doi: 10.3389/fphar.2018.00350, PMID 29695966

Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm BE, Wahlin A, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002;11:65-72. doi: 10.1002/pds.667, PMID 11998554

Published

07-07-2023

How to Cite

Valder, B. K., N. P, N. GK, and S. GN. “A STUDY TO ASSESS, MONITOR, AND REPORTING OF ADVERSE DRUG REACTIONS IN A TERTIARY CARE TEACHING HOSPITAL: HIMS, HASSAN”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 7, July 2023, pp. 201-3, doi:10.22159/ajpcr.2023.v16i7.46654.

Issue

Section

Original Article(s)